Type 2 Diabetes in Obese Children Proves Difficult to Treat with Drugs Alone
Metformin, "the only pill approved in the U.S. for treatment of children with type 2 diabetes is proving surprisingly ineffective, according to a new...
Resurgence of Pharma Lobbying Spending
According to Open Secrets, which tracks industry lobbying, "the pharmaceutical industry as a whole spent $69.6 million on lobbying in the first three months"...
Novo Nordisk is Back on Pinterest with Patient Stories
Novo Nordisk is back on Pinterest! Recall that Novo "de-pinned" all its images a few days after I first discovered them on Pinterest (see...
Device Makers, e.g. Johnson & Johnson, May Benefit Most from FDA User Fee Bill
"Put simply," says AdvaMed, the trade association of the medical device industry, "the is good for FDA; it is good for industry; and...
As Pharma Spends More on Digital, External Digital Agencies Receive Poor Ratings from Marketing...
Pharmaceutical brand teams are generally dissatisfied with their outsourced digital marketing, according to a study by Cutting Edge Information (see press release).
In surveys and...
Janssen Uses Digital Storytelling, Animation to “Bring Prescription Medicine Labeling to Life.” But Not...
Have you ever seen those animated stories any one can create using a service called "Xtranormal?" According to the web site, "Xtranormal helps you...
New Victoza Prescriptions Flatten After Novo Signs Deal with Paula Deen
New prescriptions written per month for Victoza -- diabetes treatment sold by Novo Nordisk -- have leveled off just after Novo signed on celebrity chef Paula...
Pharma Marketing News Vol. 11, No. 4: 19 April 2012
Welcome to Volume 11, Issue #4 (19 APRIL 2012) of Pharma Marketing News.
Lipitor Holds Key to DTC Ad Spending in 2012
As reported by Nielsen, direct-to-consumer (DTC) advertising spending by the pharmaceutical industry was down by 1% compared to 2010. I did a little exercise to predict that DTC spending in 2012 will see a further 3% decrease compared to 2011 solely due to an expected drop in Lipitor advertising. Here's how I came up with that estimate.
Sanofi Launches Diabetapedia: “Google” for Diabetes
Laura Kolodjeski (@lkolodjeski), Community Manager for Sanofi US Diabetes, sent me a Twitter DM announcing the launch of Diabetapedia (di-ah-bee-tah-pee-dee-ah), a new site 'to help meet educational needs of diabetes community.' According to Laura, the goal is to create 'a single, comprehensive place where anyone can find and share definitions of diabetes-related terms and phrases.' The site's tag line is 'Diabetes doesn't define you... so define diabetes.'
